Skip to main content
Premium Trial:

Request an Annual Quote

Berkeley Lights Reports Preliminary Q3 Revenues Grow Approximately 33 Percent

NEW YORK – Berkeley Lights said on Tuesday that it expects preliminary third quarter revenue growth of approximately 33 percent.

For the three months ended Sept. 30, the company expects record total revenues in the range of $24 million to $24.3 million and said it placed 13 platforms, including three subscriptions, also a record.

"Our results this quarter are a testament to the value and broad applicability of the Berkeley Lights platform across multiple disciplines," CEO Eric Hobbs said in a statement.

Based in Emeryville, California, Berkeley Lights makes instruments for cell sorting and analysis based on so-called "optofluidic" technology.

The firm expects to report its full Q3 financial results on Nov. 4.

In early morning trading on the Nasdaq, shares of Berkeley Lights were up 11 percent at $20.71.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.